On February 16th 2018 I gave a keynote address for the session “Emerging global trends in self-care and relevance of OTC regulatory framework for Indian public healthcare system” as part of the India Pharma & India Medical Device 2018 conference organised by the Federation of Indian Chambers of Commerce & Industry. The presentation was part...
In July 2017 a study I edited was released: a major report on cancer control in Latin America, with a focus on inequality in access to care. The report is based on the Latin America Cancer Control Scorecard (LACCS), which assesses cancer-control policies and programmes in 12 Latin American countries.
In June 2017 I presented the results of a major new index on global access to healthcare at a conference organised by The Economist Events.
In May 2017 a study on global heart health that I edited was published following a pre-launch at a major heart health conference in London in November 2016.
For Davos 2017 The Economist Intelligence Unit has released a new report on the impact of non-communicable diseases in developing countries. I was the lead editor of the study.
In this report that I edited, we look at the current national and EU-level approaches to obesity policy, identify the weaknesses in current efforts, and discuss how strategies might be adapted to confront the scale of the obesity problem more effectively.
A combination of major lifestyle and dietary changes over the past few decades, harsh weather conditions that limit outdoor activities and a genetic predisposition has led to an obesity crisis in many parts of the Middle East. A report on this topic that I edited has just been published.
Value-based healthcare looks at health outcomes of treatment relative to cost. In a series of reports that I edited we examined the way in which value is interpreted across Europe, the extent to which European countries are adopting cost-effectiveness as a key criterion for assessing it, and the efforts to develop new pricing models.
A report that I edited assesses the current status and potential impact of diabetes in the six Gulf Co-operation Council states—Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the UAE; reviews current approaches to tackling the disease in the region; and explores further possible opportunities to help combat diabetes.